Published by Josh White on 15th August 2018
(Sharecast News) - Generic drugmaker Hikma Pharmaceuticals issued its interim results for the six months ended 30 June on Wednesday, reporting an 11% improvement in group revenue to $989m, or 10% in constant currency.
URL: http://www.digitallook.com/dl/news/story/27876353/...